PMA supplement
P150031 S083: Vercise Genus, Vercise Gevia, Vercise PC, Vercise DBS Systems
FDA PMA supplement · Real-Time Process · Boston Scientific Corp
Key facts
| Original PMA | P150031 |
|---|---|
| Supplement number | S083 |
| Supplement type | Real-Time Process |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | Vercise Genus, Vercise Gevia, Vercise PC, Vercise DBS Systems |
| Generic name | Stimulator, electrical, implanted, for parkinsonian symptoms |
| Applicant | Boston Scientific Corp |
| Product code | NHL |
| Received date | Feb 21, 2025 |
| Decision date | May 20, 2025 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: